Key Highlights

  • Quantum Computing shares are trading 1.24% lower at $6.78 on Wednesday, October 28, 2026.
  • Short interest was 67.35 million shares, or 33.57% of float, with 9.86 days to cover.
  • Second-quarter revenue was $5.551 million versus $61,000 a year earlier, with a net loss of $11.753 million.
  • Cash, equivalents and investments were about $1.3 billion at June 30, 2026, down from about $1.5 billion at year-end.
  • Contract backlog was about $42.5 million, and third-quarter results are scheduled for November 9, 2026.

Quantum Computing Stock Dips: Why Are Shares Lower Despite Rising Revenue?

Quantum Computing (NASDAQ:QUBT) shares are trading 1.24% lower at $6.78 on Wednesday, October 28, 2026, implying a prior close of about $6.87 (calculated). No company release accompanied the move. The stock has fallen 57% over the past year and its 52-week range is $6.08 to $16.79.

The Hoboken, New Jersey company builds photonic quantum systems, including the Dirac-3 optimization machine and the NeuraWave reservoir computing platform. It announced the Dirac-3S, a system scaling to nearly 10,000 variables, in early October, and it said around mid-October that it would work with INmune Bio (NASDAQ:INMB) on quantum optimization for drug research.

Short Interest at 33.57% of Float: What Could It Mean for QUBT?

The latest short-interest data, updated October 27, 2026, shows 67.35 million shares sold short, up from 64.70 million a month earlier. That equals 33.57% of the float and 29.75% of shares outstanding, with 9.86 days to cover at recent volume.

A short position this large relative to the float means sharp rallies can be amplified if short sellers buy back shares, while declines can be extended when sentiment sours. The figure alone says nothing about direction.

Second-Quarter Results: How Much of the Revenue Jump Came From Acquisitions?

Revenue for the quarter ended June 30, 2026 was $5.551 million, up from $61,000 a year earlier and from $3.7 million in the first quarter, driven mainly by photonics products. Cost of revenue was $6.717 million, leaving a gross loss of $1.166 million. Operating expenses rose 114% to $21.847 million, including $7.3 million of acquisition-related costs.

The net loss narrowed to $11.753 million, or $0.05 per share, from $36.482 million, or $0.26, as a derivative mark-to-market loss shrank to $1.682 million from $28.096 million and interest and other income reached $12.954 million. Contract backlog was about $42.5 million.

NHanced Deal and the $1.3 Billion Treasury: What Is the Company Spending On?

On June 22, 2026 the company completed the purchase of NHanced Semiconductors, an advanced packaging foundry, for $68.1 million of closing cash and $5.0 million of stock. A further $20.0 million sits in escrow tied to fiscal 2027 and 2028 revenue, and earnouts could add up to $72.0 million. It was the third acquisition of the year, after Luminar Semiconductor and NuCrypt, and about $180 million of cash went to the three deals.

Cash and investments were about $1.3 billion at June 30, made up of $189.2 million in cash, $765.0 million in short-term investments and $369.3 million in long-term investments. Total liabilities were $47.2 million and equity was $1.59 billion on 226.3 million shares. Market capitalisation was about $1.48 billion at the October 27 quote.

What to Watch Next: November 9 Results and the Pace of Cash Use

The company will host its third-quarter results call on November 9, 2026. Investors will look for revenue progress from the NHanced facility, further cash use on acquisitions, and any change in short interest. A research firm, Rosenblatt, reiterated a $22 price target around October 20, cited here as a data point.